Recent insights about pyrrolidine core skeletons in pharmacology

To overcome numerous health disorders, heterocyclic structures of synthetic or natural origin are utilized, and notably, the emergence of various side effects of existing drugs used for treatment or the resistance of disease-causing microorganisms renders drugs ineffective. Therefore, the discovery...

Full description

Bibliographic Details
Main Authors: Samet Poyraz, H. Ali Döndaş, Naciye Yaktubay Döndaş, José M. Sansano
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1239658/full
_version_ 1827823138567618560
author Samet Poyraz
H. Ali Döndaş
H. Ali Döndaş
Naciye Yaktubay Döndaş
José M. Sansano
author_facet Samet Poyraz
H. Ali Döndaş
H. Ali Döndaş
Naciye Yaktubay Döndaş
José M. Sansano
author_sort Samet Poyraz
collection DOAJ
description To overcome numerous health disorders, heterocyclic structures of synthetic or natural origin are utilized, and notably, the emergence of various side effects of existing drugs used for treatment or the resistance of disease-causing microorganisms renders drugs ineffective. Therefore, the discovery of potential therapeutic agents that utilize different modes of action is of utmost significance to circumvent these constraints. Pyrrolidines, pyrrolidine-alkaloids, and pyrrolidine-based hybrid molecules are present in many natural products and pharmacologically important agents. Their key roles in pharmacotherapy make them a versatile scaffold for designing and developing novel biologically active compounds and drug candidates. This review aims to provide an overview of recent advancements (especially during 2015–2023) in the exploration of pyrrolidine derivatives, emphasizing their significance as fundamental components of the skeletal structure. In contrast to previous reviews that have predominantly focused on a singular biological activity associated with these molecules, this review consolidates findings from various investigations encompassing a wide range of important activities (antimicrobial, antiviral, anticancer, anti-inflammatory, anticonvulsant, cholinesterase inhibition, and carbonic anhydrase inhibition) exhibited by pyrrolidine derivatives. This study is also anticipated to serve as a valuable resource for drug research and development endeavors, offering significant insights and guidance.
first_indexed 2024-03-12T02:07:55Z
format Article
id doaj.art-1b21c64d4098409f8f100407dd0da132
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-12T02:07:55Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-1b21c64d4098409f8f100407dd0da1322023-09-06T19:51:13ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-09-011410.3389/fphar.2023.12396581239658Recent insights about pyrrolidine core skeletons in pharmacologySamet Poyraz0H. Ali Döndaş1H. Ali Döndaş2Naciye Yaktubay Döndaş3José M. Sansano4Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Çukurova University, Adana, TürkiyeDepartment of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Çukurova University, Adana, TürkiyeDepartment of Biotechnology, Institute of Natural and Applied Sciences, Çukurova University, Adana, TürkiyeDepartment of Pharmacology, Faculty of Medicine, Çukurova University, Adana, TürkiyeDepartment of Organic Chemistry, Centro de Innovación en Química Avanzada (ORFEO-CINQA), Instituto de Síntesis Orgánica (ISO), University of Alicante, Alicante, SpainTo overcome numerous health disorders, heterocyclic structures of synthetic or natural origin are utilized, and notably, the emergence of various side effects of existing drugs used for treatment or the resistance of disease-causing microorganisms renders drugs ineffective. Therefore, the discovery of potential therapeutic agents that utilize different modes of action is of utmost significance to circumvent these constraints. Pyrrolidines, pyrrolidine-alkaloids, and pyrrolidine-based hybrid molecules are present in many natural products and pharmacologically important agents. Their key roles in pharmacotherapy make them a versatile scaffold for designing and developing novel biologically active compounds and drug candidates. This review aims to provide an overview of recent advancements (especially during 2015–2023) in the exploration of pyrrolidine derivatives, emphasizing their significance as fundamental components of the skeletal structure. In contrast to previous reviews that have predominantly focused on a singular biological activity associated with these molecules, this review consolidates findings from various investigations encompassing a wide range of important activities (antimicrobial, antiviral, anticancer, anti-inflammatory, anticonvulsant, cholinesterase inhibition, and carbonic anhydrase inhibition) exhibited by pyrrolidine derivatives. This study is also anticipated to serve as a valuable resource for drug research and development endeavors, offering significant insights and guidance.https://www.frontiersin.org/articles/10.3389/fphar.2023.1239658/fullpyrrolidinepyrrolidine 2,5-dionenatural productscytotoxicitypharmaceuticals
spellingShingle Samet Poyraz
H. Ali Döndaş
H. Ali Döndaş
Naciye Yaktubay Döndaş
José M. Sansano
Recent insights about pyrrolidine core skeletons in pharmacology
Frontiers in Pharmacology
pyrrolidine
pyrrolidine 2,5-dione
natural products
cytotoxicity
pharmaceuticals
title Recent insights about pyrrolidine core skeletons in pharmacology
title_full Recent insights about pyrrolidine core skeletons in pharmacology
title_fullStr Recent insights about pyrrolidine core skeletons in pharmacology
title_full_unstemmed Recent insights about pyrrolidine core skeletons in pharmacology
title_short Recent insights about pyrrolidine core skeletons in pharmacology
title_sort recent insights about pyrrolidine core skeletons in pharmacology
topic pyrrolidine
pyrrolidine 2,5-dione
natural products
cytotoxicity
pharmaceuticals
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1239658/full
work_keys_str_mv AT sametpoyraz recentinsightsaboutpyrrolidinecoreskeletonsinpharmacology
AT halidondas recentinsightsaboutpyrrolidinecoreskeletonsinpharmacology
AT halidondas recentinsightsaboutpyrrolidinecoreskeletonsinpharmacology
AT naciyeyaktubaydondas recentinsightsaboutpyrrolidinecoreskeletonsinpharmacology
AT josemsansano recentinsightsaboutpyrrolidinecoreskeletonsinpharmacology